EDGAR Filing Documents for 0001176256-14-000194

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001176256-14-000194

Filing Date

2014-05-06

Accepted

2014-05-06 15:11:40

Documents

Period of Report

2014-05-06

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN ISSUER FOR MAY 6, 2014	nymox6knr140506.htm	6-K	5205
2	NEWS RELEASE DATED MAY 6, 2014	exhibit99-1.htm	EX-99.1	6260
3		exhibit99-1x1x1.jpg	GRAPHIC	3136
	Complete submission text file	0001176256-14-000194.txt		16963

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 14816701
SIC: 2835 In Vitro & In Vivo Diagnostic Substances